Majority stake in HumanOptics AG to be sold to Chinese investor

Ad-hoc-Mitteilung gemäß Art. 17 MAR

Erlangen, August 30, 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, ("Medipart") that Medipart signed a share purchase agreement to sell its stake of 73.4% in the share capital of the Company to a Chinese investor today. The closing of the sale is subject to the fulfillment to customary closing conditions, including approvals by Chinese public authorities.

End of the Ad-hoc-Disclosure

Contact:
HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com

Ad-hoc-Disclosure, 30.08.2019

    *Mandatory field

    HumanOptics expands production site in Germany

    News
    News

    In the final phase of last year, several important major investments were approved in line with HumanOptics Holding AG’s growth strategy. These will be implemented in the course of 2024 and will significantly increase production capacity by fully committing to the Germany location. The implementation of these measures has already begun, so that a significant […]